Bio: Peng Jiang started his research program at the National Cancer Institute in July 2019 and was awarded tenure in July 2025. His lab focuses on developing big-data and artificial intelligence frameworks to identify biomarkers and new therapeutic approaches for cancer immunotherapies in solid tumors. Before joining NCI, he finished his postdoctoral training at the Dana Farber Cancer Institute and Harvard University.
Peng finished his Ph.D. at the Department of Computer Science & Lewis Sigler Genomics Institute at Princeton University, and his undergraduate study with the highest national honors at the Department of Computer Science at Tsinghua University, Beijing. He is a recipient of the NCI K99 Pathway to Independence Award, the Scholar-In-Training Award of the American Association of Cancer Research, the Technology Innovation Award of the Cancer Research Institute, and the NCI Director’s Award of Data Science.
